MedTrace Logo

Effect of Androgen Deprivation Therapy on Cardiovascular Function in Prostate Cancer

NCT03275181 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2025-09-02

No results posted yet for this study

Summary

The aim of this project is to determine whether androgen deprivation therapy (ADT) decreases left ventricular function in prostate cancer patients. If found successful, this may lead to improved cardiovascular health via treatment and/or lifestyle interventions in prostate cancer populations.

Conditions

Interventions

DIAGNOSTIC_TEST

Transthoracic Echocardiography

Non-invasive assessment of left ventricle structure and function

DIAGNOSTIC_TEST

Arterial blood pressure

Continuously monitored for 5-30 minutes via finger photoplethysmography

DIAGNOSTIC_TEST

Submaximal Exercise

Incremental exercise test to 85% predicted maximal heart rate on a recumbent cycle ergometer

Sponsors & Collaborators

  • Kansas State University

    lead OTHER

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-08-01
Primary Completion
2018-07-31
Completion
2018-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03275181 on ClinicalTrials.gov